Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Birch

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cephalalgia : an International Journal of Headache|October 1, 1990
Lack of antinociceptive activity of sumatriptan in rodentsM Skingle, P J Birch, G E Leighton, et al.
British Journal of Pharmacology|July 1, 1995
Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cordB A Chizh, M J Cumberbatch, P J Birch, et al.
Nature|August 1, 1970
Antiviral activity of double stranded RNA and virus-like particles from Penicillium stoloniferumD N Planterose, P J Birch, D J Pilch, et al.
European Journal of Pharmacology|December 15, 1987
Norbinaltorphimine: antagonist profile at kappa opioid receptorsP J Birch, A G Hayes, M J Sheehan, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1988
In-vivo studies with the opioid antagonist, 16-methylcyprenorphineP J Birch, A G Hayes, M J Sheehan, et al.
Journal of Clinical Pathology|July 1, 1995
Longstanding proliferation of CD3 negative large granular lymphocytes preceding the development of high grade non-Hodgkin's lymphomaS R Smith, P G Middleton, P J Birch, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1990
The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptorsH Rogers, A G Hayes, P J Birch, et al.
Journal of Medicinal Chemistry|July 8, 1994
4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective kappa-receptor agonistsA Naylor, D B Judd, D I Scopes, et al.
Neuroscience Letters|January 3, 1994
Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammationG D Smith, J Wiseman, S M Harrison, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cephalalgia : an International Journal of Headache|October 1, 1990
Lack of antinociceptive activity of sumatriptan in rodentsM Skingle, P J Birch, G E Leighton, et al.
British Journal of Pharmacology|July 1, 1995
Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cordB A Chizh, M J Cumberbatch, P J Birch, et al.
Nature|August 1, 1970
Antiviral activity of double stranded RNA and virus-like particles from Penicillium stoloniferumD N Planterose, P J Birch, D J Pilch, et al.
European Journal of Pharmacology|December 15, 1987
Norbinaltorphimine: antagonist profile at kappa opioid receptorsP J Birch, A G Hayes, M J Sheehan, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1988
In-vivo studies with the opioid antagonist, 16-methylcyprenorphineP J Birch, A G Hayes, M J Sheehan, et al.
Journal of Clinical Pathology|July 1, 1995
Longstanding proliferation of CD3 negative large granular lymphocytes preceding the development of high grade non-Hodgkin's lymphomaS R Smith, P G Middleton, P J Birch, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1990
The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptorsH Rogers, A G Hayes, P J Birch, et al.
Journal of Medicinal Chemistry|July 8, 1994
4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective kappa-receptor agonistsA Naylor, D B Judd, D I Scopes, et al.
Neuroscience Letters|January 3, 1994
Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammationG D Smith, J Wiseman, S M Harrison, et al.
Pageof 5